BioSpace News Archive

SanBio Company Limited announced it has concluded an agreement with Keio University School of Medicine on joint research for SB623 targeting dementia.

Telmediq announced today that it has been listed as a Representative Vendor in Gartner’s 2018 Market Guide for Clinical Communication and Collaboration.

Series C funding led by Draper Esprit

SARM1 deletion protects axons and prevents increases in neurofilament light chain (NF-L), a biomarker of axonal degeneration

And expands production capabilities through acquisition of TailorMed Ltd.

A new California Workers’ Compensation Institute (CWCI) analysis offers a preliminary look at Utilization Review (UR) and Independent Medical Review (IMR) outcomes involving pharmaceutical requests for California injured workers since the state implemented a workers’ comp formulary in January of this year.

Isogenica Ltd today announced that it has signed a new licensing agreement with Aro Biotherapeutics Company (Aro) of Philadelphia.

On Friday, key US indices were bearish as the NASDAQ Composite finished the trading session down 0.07%; the Dow Jones Industrial Average edged 0.03% lower; and the S&P 500 was down 0.09%.

Aerie Pharmaceuticals, Inc. reported that it has received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) earlier than scheduled, the FDA has completed its initial 60-day review of the NDA (new drug application) for Roclatan™

Lannett Company, Inc. announced that it launched four products in June 2018, bringing to seven the total number of products launched since January 1, 2018.